DK549589A - NEOGLYCOPROTEINES, THEIR PREPARATION AND USE - Google Patents

NEOGLYCOPROTEINES, THEIR PREPARATION AND USE

Info

Publication number
DK549589A
DK549589A DK549589A DK549589A DK549589A DK 549589 A DK549589 A DK 549589A DK 549589 A DK549589 A DK 549589A DK 549589 A DK549589 A DK 549589A DK 549589 A DK549589 A DK 549589A
Authority
DK
Denmark
Prior art keywords
neoglycoproteins
neoglycoproteines
preparation
monosialolactose
disialolactose
Prior art date
Application number
DK549589A
Other languages
Danish (da)
Other versions
DK549589D0 (en
Inventor
Herbert Wiegand
Silke Bosslet
Klaus Bosslet
Hans Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK549589D0 publication Critical patent/DK549589D0/en
Publication of DK549589A publication Critical patent/DK549589A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The synthesis and use of neoglycoproteins is described. Monosialolactose and disialolactose are isolated from cow colostrum and coupled using a coupling reagent to human serum albumin (HSA) as carrier protein. These neoglycoproteins are suitable as vaccines and as ligands for the localisation and therapy of lectin-expressing tumour tissues.
DK549589A 1988-11-05 1989-11-03 NEOGLYCOPROTEINES, THEIR PREPARATION AND USE DK549589A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3837623A DE3837623A1 (en) 1988-11-05 1988-11-05 NEOGLYCOPROTEINS, THEIR PRODUCTION AND USE

Publications (2)

Publication Number Publication Date
DK549589D0 DK549589D0 (en) 1989-11-03
DK549589A true DK549589A (en) 1990-05-06

Family

ID=6366580

Family Applications (1)

Application Number Title Priority Date Filing Date
DK549589A DK549589A (en) 1988-11-05 1989-11-03 NEOGLYCOPROTEINES, THEIR PREPARATION AND USE

Country Status (12)

Country Link
EP (1) EP0368131B1 (en)
JP (1) JP2838147B2 (en)
KR (1) KR0162635B1 (en)
AT (1) ATE142229T1 (en)
AU (1) AU630634B2 (en)
CA (1) CA2002218C (en)
DE (2) DE3837623A1 (en)
DK (1) DK549589A (en)
ES (1) ES2093612T3 (en)
GR (1) GR3021111T3 (en)
IE (1) IE76312B1 (en)
PT (1) PT92187B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3840044A1 (en) * 1988-11-27 1990-06-07 Behringwerke Ag GLYCOSPHINGOLIPIDS WITH A COUPLABLE GROUP IN THE SPHINGOID PART, THEIR PRODUCTION AND USE
EP0646377A1 (en) * 1993-10-01 1995-04-05 LUANFARMA S.r.l. Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof
US5612030A (en) 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
AU6485496A (en) * 1995-07-14 1997-02-18 Glycotech Corp. Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
DE3840044A1 (en) * 1988-11-27 1990-06-07 Behringwerke Ag GLYCOSPHINGOLIPIDS WITH A COUPLABLE GROUP IN THE SPHINGOID PART, THEIR PRODUCTION AND USE

Also Published As

Publication number Publication date
JPH02173000A (en) 1990-07-04
PT92187A (en) 1990-05-31
CA2002218A1 (en) 1990-05-05
EP0368131B1 (en) 1996-09-04
AU4436889A (en) 1990-05-10
IE76312B1 (en) 1997-10-22
ES2093612T3 (en) 1997-01-01
KR900007429A (en) 1990-06-01
KR0162635B1 (en) 1998-11-16
ATE142229T1 (en) 1996-09-15
DE3837623A1 (en) 1990-05-10
PT92187B (en) 1995-06-30
DK549589D0 (en) 1989-11-03
EP0368131A2 (en) 1990-05-16
IE893548L (en) 1990-05-05
DE58909720D1 (en) 1996-10-10
GR3021111T3 (en) 1996-12-31
CA2002218C (en) 2000-08-08
EP0368131A3 (en) 1990-12-19
AU630634B2 (en) 1992-11-05
JP2838147B2 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
NO831317L (en) PROCEDURE FOR THE PREPARATION OF FUNCTIONAL HUMAN-UROKINASE PROTEINS.
DK0733067T3 (en) N-terminally chemically modified protein preparations and methods
DE69329538D1 (en) Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical preparations containing them
FI885543A (en) DNA SEGMENT, POLYPEPTIDER OTI ANTI-CROPPAR ANSLUTANDE TILL HUMAN VAEVNADSFAKTOR.
NO872966L (en) PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS.
DE3873397D1 (en) BIFUNCTIONAL PROTEINS.
DK235687A (en) PREPARATIONS FOR SYNTHESIS OF PROSTAGLANDINES AND HYDROXYPHETIC ACIDS IN BIOLOGICAL SYSTEMS AND APPLICATION THEREOF
DK549589A (en) NEOGLYCOPROTEINES, THEIR PREPARATION AND USE
IT8483359A0 (en) PROCEDURE TO OBTAIN THE PREPARATION OF PROTEIN CONCENTRATES AND NUTRIENTS FROM ANIMAL BLOOD.
SE8404283L (en) APPLICATION OF A SPECIFIC TUMORALLY ASSOCIATED ANTIGEN, namely SIALOSYLLACTOTETRAUS, FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR CANCER DISEASES
DK402485D0 (en) TUMOR THERAPEUTIC AND PROCEDURE FOR ITS PREPARATION
DK304090D0 (en) GLYCEROLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATIONS CONTAINING THESE
DK493988D0 (en) 4-OXO-3-QUINOLINCARBOXYLIC ACIDS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
ZA875676B (en) The use of 15-deoxyspergualine as a pharmaceutical
DK299590A (en) PHOSPHOLIPID DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATIONS CONTAINING THESE
AU5752490A (en) A novel tumor associated antigen
EP0243058A3 (en) A novel tumor associated antigen
NO883674D0 (en) 5-HYDROXY-3-AMINOCROMAN COMPOUNDS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND METHODS OF TREATMENT THEREOF.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment